AXIM Biotechnologies, Inc.
Income Statement
| Line Item | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 |
|---|---|---|---|---|---|
| Revenue | $49.1K | $0 | $21.7K | $43.3K | $10.0K |
| Cost of Revenue | $50.4K | $0 | — | — | — |
| Gross Profit | $-1.2K | $0 | — | — | — |
| Gross Margin | -2.5% | — | — | — | — |
| Operating Expenses | |||||
| Research & Development | $571.5K | $0 | — | — | — |
| SG&A Expense | $9.5M | $505.7K | — | — | — |
| Operating Income | $-10.0M | $-505.7K | — | — | — |
| Operating Margin | -20,451.3% | — | — | — | — |
| Interest Expense | $43.2K | $32.5K | — | — | — |
| Pretax Income | $-10.1M | $-538.3K | — | — | — |
| Income Tax Expense | $0 | $0 | — | — | — |
| Net Income | $-10.1M | $-582.9K | $-89.2K | $-14.9K | $-2.8K |
| Net Margin | -20,539.2% | — | -411.8% | -34.4% | -27.9% |
| EPS (Basic) | $-0.27 | $-0.02 | $0.00 | — | $0.00 |
| EPS (Diluted) | $-0.27 | $-0.02 | $0.00 | — | $0.00 |
| Shares Outstanding (Basic) | 39.6M | 33.0M | 33.0M | 33.0M | — |
| Shares Outstanding (Diluted) | 39.6M | 33.0M | 33.0M | 33.0M | 23.3M |
| Dividends Per Share | — | — | — | — | — |